• 

  August 29, 2025

  Treatment of Stage IV- Metastatic or Recurrent Colon Cancer

  Charles H. Weaver, MD

• 

  August 24, 2025

  Precision Cancer Medicines for Colon Cancer

  Charles H. Weaver, MD

• 

  February 2, 2024

  Targeting KRAS G12C mutations in colon, lung, and other cancers

  Charles H. Weaver, MD

• 

  September 14, 2023

  Lumakras (sotorasib,AMG 510) Precision Cancer Medicine Targets KRAS NSCLC

  Charles H. Weaver, MD

• 

  September 11, 2023

  Targeting KRAS G12C Cancer Mutations

  Charles H. Weaver, MD

• 

  March 24, 2021

  Keytruda in Non-Small Cell Lung Cancer

  Charles H. Weaver, MD

• 

  February 2, 2021

  Precision Cancer Medicines & Immunotherapy for Lung Cancer

  Charles H. Weaver, MD

• 

  November 30, 2020

  Drugs in Development for Advanced GI Cancers

  Charles H. Weaver, MD

• 

  September 21, 2020

  Onvansertib Precision Medicine Being Developed for KRAS mutant Colon Cancers

  Charles H. Weaver, MD